Deutsche Bank sees more than a 30% rally for this specialty biotech stock
Deutsche Bank upgraded Catalent on Monday to buy from hold as the company's partnership with Moderna could help it grow market share.
Source link
Deutsche Bank upgraded Catalent on Monday to buy from hold as the company's partnership with Moderna could help it grow market share.
Source link